You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) – French firm Cellectis and North Carolina-based Precision Biosciences have filed two new suits against each other alleging infringement of US patents covering modified meganucleases.
Helix will promote Cellectis' Genome Positioning System line of products and services in India.
The French firm gains access to Cyto Pulse's electroporation technologies and equipment.
Cedarlane will distribute Cellectis Bioresearch's kits in Canada.
The patent has been the subject of ongoing litigation between the French and US biotech firms.
The agricultural products company will use Cellectis' meganuclease tools and will invest in the French firm.
Nature News reports on the US National Science Foundation's investigations of undisclosed foreign ties among researchers it funds.
Researchers have developed a set of 10 principles to guide how a list of all species on earth should be put together, the Guardian reports.
Wired reports on a new firm developing a gene writing approach for therapeutic genome changes.
In Nature this week: a method called cis-X combines whole-genome and transcriptome sequencing data to identify regulatory noncoding variants, and more.